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ABSTRACT
Potent second-generation anticoagulant rodenticides such as
brodifacoum have been used as more effective alternatives to
first-generation anticoagulants, such as warfarin. A combination of
diphacinone at 0.005% and cholecalciferol at 0.06% produces a
slow-acting bait that is effective at killing possums (Trichosurus
vulpecula) and rodents. Cage trials with groups of possums and
ship rats (Rattus rattus) achieved a mortality of 87% and 86% for
possums and ship rats, respectively. Two field trials, each 200
hectares in size, targeting possums, ship rats and mice achieved
an average reduction in the abundance of 94% for possums, 94%
for ship rats and 80% for mice. The combination of diphacinone
and cholecalciferol appears effective and has a favourable risk
profile compared with second-generation anticoagulant
rodenticides, such as brodifacoum. Approval of this new bait by
the New Zealand Environmental Protection Agency was granted
in 2018 and final registration obtained from the Ministry of
Primary Industries in 2019.
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Prior to 1950 all vertebrate pesticides used worldwide were non-anticoagulants, most of
them acute or quick acting, but after the introduction of warfarin and the other anticoagu-
lants, the importance of these non-anticoagulants was somewhat reduced, at least for
rodent control (Eason et al. 2017). However, in New Zealand, because of our conservation
needs and TB management challenges (Livingstone et al. 2015) there are six acute acting
poisons currently registered for possum control: 1080 (sodium fluoroacetate), cyanide,
cholecalciferol (Vitamin D3), zinc phosphide, sodium nitrite and phosphorus. 1080 and
cholecalciferol can be used for the control of rodents as well as possums. Sodium nitrite
has been developed for control of possums and feral pigs and is particularly humane com-
paring well with cyanide (Shapiro et al. 2016). In an optimisedmammalian pest control tool
box there will be both fast-acting acute toxins and slower acting anticoagulants (Eason et al.
2017), for example, where maintenance control of low-density possum populations and
long-term suppression or elimination of possum populations is a requirement, and
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neophobia or trap or bait-shyness may develop if acute toxins or traps are used repeatedly.
Globally, anticoagulants have been used for control of commensal rodents, primarily
Norway rats (Rattus norvegicus), ship rats (Rattus rattus) and house mice (Mus musculus).
Brodifacoum is the most widely used slow-acting rodenticide worldwide and is highly
effective for controlling both rodents and possums. Two anticoagulants are registered for
possum and rodent control, namely brodifacoum and pindone. However, first-generation
anticoagulants like pindone or diphacinone are not effective against possums at current bait
concentrations (Eason et al. 1994, 2017). The anticoagulant effect of these compounds in
possums is quite different from that seen in rats. For example, after a lethal dose of brodi-
facoummost rats will die within a week whereas, possums will take 2–4 weeks to die (Littin
et al. 2002). Additionally, very large amounts of baits containing first-generation anticoa-
gulants alone have to be eaten by possums compared with rats for baits to be effective which
is costly, and combined with their questionable effectiveness the only anticoagulant
effective for controlling possums is brodifacoum (Eason et al. 2017).
Unfortunately, brodifacoum and other second-generation anticoagulants have a ten-
dency to bioaccumulate and cause secondary poisoning which has advantages in some situ-
ations, but not where there are concerns regarding residues, food safety and non-target
impacts (Eason et al. 1996, 1999, 2010a, 2010b). Widespread second-generation anticoagu-
lant exposure in non-target species has been documented globally, including the USA
(Murray 2011), Norway (Langford et al. 2013), Denmark (Christensen et al. 2012), Great
Britain (Walker et al. 2014), Spain (Lopez-Perea et al. 2015), Australia (Young and De
Lai 1997), New Zealand (Eason et al. 1999) and Malaysia (Salim et al. 2015) and in some
cases long-term studies have explicitly demonstrated an increasing trend in exposure inci-
dence and residue concentration over time (Walker et al. 2014). Persistence has been associ-
ated with wildlife contamination of native birds as well as game species (Young and De Lai
1997; Eason et al. 1999, 2002, 2010a; Stone et al. 1999, 2010b, 2017; US EPA 2008).
Hence, there has been an interest in researching the combination of the first-generation
anticoagulant with cholecalciferol, as this combination has been proven to be effective in
rodents resistant to first-generation anticoagulants alone (Pospischil and Schnorbach
1994). The potential to produce bait that is as potent as brodifacoum for possum and
rodent control (Eason et al. 2008), without significant residue concerns is important. A
bait containing diphacinone and a very small amount of cholecalciferol, as an additive,
will potentially meet the specification of being ‘low residue’ (i.e. less persistent), slow-
acting, lower cost and should be safer for non-target species. It has been developed in
New Zealand for the control of possums and rats and in parallel has been researched
for the control of California voles (Microtus californicus), an agricultural pest in the US
(Witmer et al. 2014; Baldwin et al. 2016).
Diphacinone has been identified as the anticoagulant of choice for this combination
bait because of its short half-life (Crowell et al. 2013). Diphacinone is a first-generation
anticoagulant toxin that was developed in the USA and first used in New Zealand in
the 1950s. Cholecalciferol (vitamin D3) was developed in the 1980s as a rodenticide (Mar-
shall 1984; Tobin et al. 1993). Cholecalciferol is registered in New Zealand for rodent and
possum control in baits at 0.8% and 0.4%. It is registered under the trade name of Terad3®
(0.075% cholecalciferol) in the USA, and in Europe it has, as mentioned above, been added
to baits containing a first-generation anticoagulant, namely coumatetralyl (Racumin® plus)
to overcome anticoagulant resistance in rats and mice (Pospischil and Schnorbach 1994).
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The bait containing diphacinone at 0.005% and cholecalciferol at 0.06%. (D + C) has been
developed as a ‘lower risk’ alternative to baits containing brodifacoum at 0.002%(PestOff®
solid cereal bait). Diphacinone is also considerably less persistent than coumatetralyl.
More detailed reviews of the characteristics, international application and toxicology of
these compounds can be found elsewhere (Prakash 1998; Hayes and Laws 1991; Eason
et al. 2010a, 2017; Buckle and Eason 2015). This paper contains details of cage and
pilot field trials on the effectiveness of paste bait at controlling possums and ship rats
and a ‘desktop’ risk versus benefit assessment of secondary poisoning, residues and
non-target risks. In New Zealand forests, house mice are a key food source for stoats
(Mustela erminea) and feral cats (Felis catus) and the high numbers of mice directly con-
tribute to higher rates of predation for native birds (Ruscoe and Murphy 2005). Due to
this, we also monitored the numbers of mice in the field trial to assess the potential of
this compound for mice control.
Methods
There are two experiment sections, covering cage and pilot field trials and one desk top
risk analysis section based on a literature review. Solid extruded cereal baits containing
a combination of diphacinone at 0.005% and cholecalciferol at 0.06% (D + C) were pre-
pared by Connovation Ltd., East Tamaki, Auckland, New Zealand and used for all the
trials described below. Prior to cage and field trials, a sample of bait was assayed by Land-
care Research who confirmed the concentrations of the diphacinone (Assay T5931) and
cholecalciferol (Assay T5930) active ingredients.
Cage trials
Sixteen possums and 16 ship rats were captured from the wild and transported to the
Centre for Wildlife Management and Conservation (CWMC) possum enclosures at the
Johnston Memorial Animal Facility at Lincoln University. On arrival, possums were
sedated and given a health check, sexed and then individually housed. Possums were
fed a maintenance diet (loose cereal mix) with water available ad libitum (following
SOP #86 Possum Husbandry). Possums were acclimatised for 10 days prior to the trial
and one possum was excluded from the trial as it was not eating well during the acclimat-
isation period. The remaining 15 possums have lightly fasted with reduced rations for 12 h
before the baits were presented. Individual possums were presented with approximately
200 g of solid extruded D + C bait in a no-choice test. Baits were weighed and then pre-
sented in the afternoon and then weighed again and removed first thing the following
morning. Normal maintenance diet was then resumed and the animals observed regularly.
Rats were fed grain pellets daily and water was available ad libitum (following SOP #36
Rat Husbandry). Two rats escaped from their cages the night of the trial and they were
excluded from the trial analysis. The remaining 14 rats were also lightly fasted on
reduced rations for 12 h before the baits were presented. Individual rats were presented
with approximately 100 g of solid extruded D + C bait. Baits were weighed and then pre-
sented in the afternoon and then weighed again and removed first thing the following
morning. After the completion of the exposure, period rats were returned to their standard
diet and observed regularly.
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Field trials
Field trials were small-scale pilot studies designed to consolidate the cage trial data to enable
product registration. Two trial sites, each 200 ha in size and separated by 500 m, were set up
in Opepe Forest located approximately 30 km south east of Taupo. A non-treatment site
also 200 ha was established 1 km away. The three sites consisted predominantly of planta-
tion pine (Pinus radiata) with some native scrub. Each site was monitored for possum and
rodent abundance prior to the start of the trial. The relative possum abundance was
measured pre- and post-poisoning using residual trap catch index (RTCI), which indicates
the number of possums trapped per 100 trap nights after adjustments are made for traps
being ‘sprung’ or catching non-target species (NPCA 2015), using Victor™ No. 1 sized
double-coil spring traps. Each of the three sites (two treatments and one control) were
set up with five lines of traps with 10 traps per line at 20 m intervals. Each line was at
least 200 m from other trap lines for statistical independence. Rodent abundance was mon-
itored pre- and post-poisoning using tracking tunnels, plastic run-through tunnels with ink
cards inside to record paw prints, set up on lines with 10 tunnels per line and 50 m between
each tunnel. Each of the three sites (two treatments and one control) were set up with five
lines of tracking tunnels. The use of these tunnels followed best practice (Gillies and Wil-
liams 2013) and tunnels were baited with peanut butter and left out for a single night and
each line was 100 m apart for statistical independence. The tracking rates were expressed as
the percentage of tunnels in each area tracked by a given species (Blackwell et al. 2002) and
adjustments to the percentage kill estimates for possums and rats were made allowing for
the natural changes observed at the control site (Morgan 2006). The trial, which included
the pre- and post-monitor of target species as well as the twomonths of toxic baiting, which
is standard practice for anticoagulant baiting, ran from May 2015 until early August 2015.
During the period of toxic baiting, the average daily rainfall was 5.2 mm (total rainfall was
317.8 mm) and the average overnight temperature was 2.9°C.
Two hundred Philproof® bait stations were used in each of the treatment blocks, at a
spacing of one per ha, and each loaded with 1 kg of D + C bait. After one month bait
stations were checked and baits weighed, and all bait stations topped up to 1 kg. After
bait had been in stations in the field for two months it was removed. Over the course
of the trial three motion-activated infrared cameras (Ltl Acorn model 5210) were used
to monitor the activity of target and non-target species at bait stations; these cameras
were moved to different bait stations every two weeks. When bait was removed, the
field research team looked for carcasses of target species and non-target species when
moving between bait stations at each site. Once all bait was removed possum and
rodent abundance was monitored following the same protocols for both species as the
pre monitor described above.
Lincoln University Animal Ethics Committee (AEC) approval was obtained for all the
trials. AEC 594 and 597 covered cage and field trials.
Literature review
Standard literature review approaches were used to further assess the risk and welfare
impact of the new baits versus other existing products. Prior to research on diphacinone
and cholecalciferol in a combination, we were pursuing a combination of coumatetralyl
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and cholecalciferol; however, this was discontinued in favour of diphacinone and chole-
calciferol, as diphacinone is less persistent and more palatable (Sam and Ross 2012).
Bait containing 0.06% cholecalciferol and 0.005% diphacinone has been developed, and
dossiers have been filed with the Environmental Protection Agency (EPA) late in 2015
to support the registration of solid bait effective at killing possums and rodents with
similar potency to brodifacoum (Eason et al. 2017). Because a substantial amount of
research was undertaken on the combination of coumatetralyl and cholecalciferol,
before research was redirected to the preferred combination of diphacinone and cholecal-
ciferol, and because the coumatetralyl and cholecalciferol combination has a similar
potency and risk profile to diphacinone and cholecalciferol, reference to some of the
earlier work on coumatetralyl and cholecalciferol was reviewed.
Results
Cage trials
Possums ate an average of 71.1 g of D + C bait and 86.67% (13/15) of possums died within
5–7 days after consuming bait (Table 1). Symptoms were not evident until two days before
death. Over the two-day period prior to death (Table 1) symptoms included lethargy,
crouching and excessive salivation and laboured breathing.
Ship rats ate an average of 10.6 g of D + C bait and 85.71% (12/14) died within 3–9 days
after consuming bait (Table 1). In the 24 h prior to death (Table 1) symptoms included
hunched posture, rough coat/pilo-erection and some fluid discharge from the eyes and
nose.
Post-mortem assessment of rats showed substantial haemorrhaging. However, the
possum is less susceptible to the haemorrhagic effect of anticoagulants, but more suscep-
tible to cholecalciferol and post-mortem assessment of possums showed a combination of
tissue calcification with some haemorrhaging.
Field trials
At site one, after treatment with bait, adjusted possum abundance dropped by 95%, ship
rat abundance by 88% and mouse abundance by 80% (Table 2). A total of 35 kg of bait was
consumed at site one over the two-month trial. At site two after bait treatment adjusted
Table 1. Average amounts of diphacinone and cholecalciferol consumed, times of behaviour changes,
death and efficacy of bait for possums and ship rats.
Feature Possums Rats
Amount of diphacinone consumed (mg ai/kg body weight) 1.29 (range 0.46–2.47) 4.51 (range 2.64–8.33)
Amount of cholecalciferol consumed (mg ai/kg body weight) 15.50 (range 5.53–29.61) 54.10 (range 31.64–100.00)
Time of reduced feed intake (days after initial ingestion) 4 (2 days prior to
death)
2 (3 days prior to death)
Time of reduced activity/symptoms (days after initial ingestion) 4 (2 days prior to
death)
4 (24 h prior to death)
Change in weight over course of trial (% weight change from start
to death/finish)
5.96 (range +8.29 to
−9.86)
11.54 (range −3.25 to
−18.85)
Number of animals killed 13/15 12/14
Time until death (days after initial ingestion) 5.77 (range 5–7) 5.08 (range 3–9)
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possum abundance dropped by 93%, ship rat abundance by 100% and mouse abundance
by 79% (Table 2). A total of 30 kg of bait was consumed at site two over the two-month
trial. The three motion-activated infrared cameras recorded possums, ship rats and mice
accessing bait stations and consuming bait. Several non-target species including blackbirds
(Turdus merula), silver eyes (Zosterops lateralis), stoats and hedgehogs (Erinaceus euro-
paeus) were recorded on cameras. However, none of these were observed accessing bait
stations. During the removal of bait at both sites, carcasses of both possums and rats
were found; however, no carcasses of non-target species were found.
Literature review
Our literature review identified extensive literature on the welfare impacts, mode of action,
residues, secondary poisoning and non-targets risk of diphacinone and cholecalciferol and
other vertebrate pesticides. This information is summarised below, and comparisons are
made between the new combination and other vertebrate pesticides. Where appropriate
the results described above are compared with published data and earlier reports.
Welfare
The time to death from previous cage trials with brodifacoum, diphacinone and cholecal-
ciferol as sole agents (Littin et al. 2000), and from coumatetralyl and cholecalciferol trials
are summarised below alongside our new data. The average time to death for rats and
possums poisoned with the combination of diphacinone and cholecalciferol was similar
or shorter than for brodifacoum alone and this is most apparent for possums.
With second-generation anticoagulants, such as brodifacoum, as sole agents, sickness is
protracted and the duration of sickness and time to death variable (Littin et al. 2000). The
authors concluded that the welfare of poisoned animals could be practically improved by
shortening the time until death using drugs that potentiate the anticoagulant action. This
aspiration by Littin et al. (2000) has been advanced with the new D + C bait (see Table 3).
Mode of action
Diphacinone is an anticoagulant vertebrate pesticide similar in toxic mechanism to other
anticoagulants such as brodifacoum. It interferes with normal blood clotting by preventing
vitamin K recycling which prevents the conversion of inactive precursors into active
vitamin K-dependent blood-clotting factors (Thijssen 1995). Major haemorrhaging and
death by respiratory or heart failure result following a lethal dose. Kerins et al. (2002)
Table 2. Pre- and post-monitoring of ship rat and possum abundance and % reduction with and
without adjustments to the percentage kill estimates – based on change at the control sites.
Site Species Pre monitor Post-monitoring % reduction not adjusted % reduction adjusted
1 Possums 6.66% 0.66% 90% 95%
1 Ship rats 26.00% 2.00% 92% 88%
1 Mice 44.00% 6.00% 86% 80%
2 Possums 10.00% 1.33% 87% 93%
2 Ship rats 12.00% 0.00% 100% 100%
2 Mice 42.00% 6.00% 86% 79%
Control Possums 2.03% 4.00% n/a n/a
Control Ship rats 16.00% 12.00% n/a n/a
Control Mice 30.00% 20.00% n/a n/a
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suggest that a low dose of cholecalciferol enhances the haemorrhagic effect of first-gener-
ation anticoagulants. Post-mortem assessment of rats containing baits shows substantial
haemorrhaging. Similar effects could be expected in most other species; however, the
possum is less susceptible to the haemorrhagic effect of anticoagulants (Eason et al.
1994), and death in possums is likely to be caused by a combination of haemorrhaging
and hypercalcaemia.
Residues
Vertebrate pesticides differ in the way they are absorbed, metabolised, distributed and
excreted, as well as the length of time that these processes take in different animals. In
the section below, we review in detail the published literature on diphacinone and chole-
calciferol and then make comparisons with other commonly used toxins.
In a comparative study of rodenticides by Fisher et al. (2003), laboratory rats were given
an oral dose of 1.5 mg/kg diphacinone and the hepatic elimination half-life was estimated
at 3 days. Residues were present 1 week after dosing but were not detected 2 weeks after
dosing. In a trial with ten pigs dosed at 1.5 mg/kg, Crowell et al. (2013) estimated a mean
hepatic elimination half-life of 12.4 days for diphacinone. Diphacinone residues in the
liver were near or below the method’s detection for a pair of pigs that were euthanised
28 days after dosing, and not detected at 43 days after dosing.
In pigs dosed at 12.5 mg/kg of diphacinone, Fisher (2006) calculated an initial and
terminal hepatic elimination half-life in recognition that elimination of anticoagulants
from the liver is often biphasic (i.e. an initial rapid phase followed by a slower terminal
phase; Parmar et al. 1987). The initial elimination half-life in liver was estimated as
1.30 days and the terminal hepatic elimination half-life in liver was estimated as 14.1
days. Diphacinone was not cleared from the livers of three pigs that were sampled at 15
days after dosing. Three red deer (Cervus elaphus scoticus) were dosed at 1.5 mg/kg dipha-
cinone and biopsied periodically by Crowell et al. (2013). A mean hepatic elimination half-
life of 6.0 days was estimated, and diphacinone residues in the liver were not detected in
two of three deer sampled at 12 days after dosing, and the third deer after 29 days (Crowell
et al. 2013).
Studies on cattle suggest that they may excrete diphacinone significantly more slowly
than other species. Bullard et al. (1976) dosed six Hereford cows with 1 mg/kg diphaci-
none by injecting it into the rumen and found that liver residues were almost identical
when analysed at 30, 60 and 90 days after treatment (0.14–0.15 mg/kg). Crowell et al.
(2013) carried out two trials in which cattle were dosed orally at 1.5 mg/kg. In both
trials, the maximum diphacinone concentration in the liver was much higher than that
Table 3. Comparative average times to death for possums and rats.
Average time to death (days)
ReferencePossums Rats
Brodifacoum 20.1 7.2 Littin et al. (2000)
Coumatetralyl+ Cholecalciferol 11.1 – Sam and Ross (2012)
Cholecalciferol – 6.4 Shapiro et al. (2011)
Cholecalciferol 7.0 Hix (2009)
Diphacinone – 6.7 Hix et al. (2010)
Diphacinone+ Cholecalciferol 5.75 5.08 This publication
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recorded in pigs and deer that had been given the same dose. A rapid initial decline in
hepatic concentration was observed before it increased on either day 43 (first trial) or
day 29 (second trial), and so initial elimination half-lives (day 0 to day 30) and terminal
elimination half-lives (from day 30 onwards) were calculated for these trials. The mean
terminal elimination half-lives were 25 and 35 days for the first and second trials respect-
ively. Diphacinone residues in the liver were below the MDL for all animals by 155 days
after dosing in the first trial and 125 days after dosing in the second trial. Based on studies
where residues were tracked until no longer detected in liver, it is expected diphacinone
would be no longer detected at about 40 days after dosing. The exception to this is in
cattle, where it may be detected at least 3 times longer. This compares favourably with
both brodifacoum and coumatetralyl (Fisher et al. 2003; Singleton et al. 2003).
Cholecalciferol residue studies. Cholecalciferol (Vitamin D3) is metabolised to 25-hydro-
xycholecalciferol (25-OHD) in the liver, with any surplus cholecalciferol either further
metabolised and excreted in bile or stored in fat and muscle tissue (Parfitt et al. 1982;
Holick 2003; Heaney et al. 2009). Further metabolism of 25-OHD in the kidneys
produces 24, 25-dihydroxycholecalciferol or 1,25-dihydroxycholecalciferol (1,25-OHD
or calcitriol).
25-OHD circulates in the blood and is the metabolite generally monitored to determine
whether an animal has consumed cholecalciferol, as it is more stable and its concentration
is more strongly correlated with cholecalciferol intake or synthesis than other metabolites
(Fairweather et al. 2013). Because 25-OHD occurs naturally in animals, Fairweather et al.
(2013) recommend excessive cholecalciferol consumption is indicated where 25-OHD
residues in plasma or liver are at least four times as high as defined reference levels for
particular species.
Persistence studies in possums orally dosed with 20 mg/kg cholecalciferol showed elev-
ated concentrations of 25-OHD are likely to persist in plasma, heart, liver, kidney and fat
for at least 29 days. 25-OHD levels declined in all tissues except fat between sampling on 3
days and 29 days after dosing (Eason et al. 1996). The authors had measured a concen-
tration of 25-OHD in plasma prior to dosing, and residues were 15 times higher than
this reference level by 29 days after dosing.
Brouwer et al. (1998) administered an oral dose of 37.5 μg cholecalciferol (being 0.20–
0.25 mg/kg) daily for 14 days to female rats. The half-lives of cholecalciferol in plasma,
perirenal and subcutaneous adipose tissue were 1.4, 97.3 and 80.9 days, respectively.
The half-life of 25-OHD in plasma was calculated as 22.5 days. 25-OHD in plasma was
still elevated 27 days after the final dose (i.e. on day 40), but by 63 days after the final
dose, the 25-OHD concentration had returned to normal (Brouwer et al. 1998).
Cattle had raised 25-OHD levels 42 days after being injected intramuscularly with
375 mg of cholecalciferol (Hollis et al. 1977). Brouwer et al. (1998) is the only study
where depletion of 25-OHD was monitored until the level could be described as
normal. This result is consistent with observations from other studies; we would expect
elevated concentrations of 25-OHD to persist in mammals for approximately 63 days
after dosing.
In all studies, diphacinone and cholecalciferol are depleted at faster rates when com-
pared with brodifacoum. Diphacinone and cholecalciferol when used together in cereal
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pellet bait are therefore less likely to lead to persistent residues and bioaccumulation in
livestock or game than brodifacoum.
Eason et al. (2010a) have previously classified these compounds into four groups, based
on their persistence in sub-lethally exposed animals. The criteria for the four groups, and the
allocation of different compounds to these groupings are described below and in Table 4.
Diphacinone falls in the low residue and cholecalciferol in the moderate category.
Group 1 –Very low residue risk compounds. Sub-lethal doses of these poisons are likely
to be substantially cleared from the body within 24 h (e.g. cyanide, zinc phosphide, PAPP
and 1080).
Group 2 – Low residue risk compounds. Residues resulting from sub-lethal doses of
these poisons are likely to be substantially cleared from the body within 2–4 weeks (e.g.
pindone and diphacinone).
Group 3 – Moderate residue risk compounds. Residues resulting from sub-lethal doses
of these poisons are likely to be cleared from the body within 2–4 months (e.g. coumate-
tralyl). Cholecalciferol is unusual as it and the active metabolite 25-OHD will be present in
blood and tissue of all animals at background reference levels (Fairweather et al. 2013) and
retained residues will present low risk when they return to normal levels in healthy
animals surviving exposure to bait, hence whilst its half-life implies moderate residue
risk it does not really fit this type of classification, which is more appropriate for a
xenobiotic.
Group 4 – High residue risk compounds. Residues resulting from sub-lethal doses of
these poisons may not ever be completely cleared from the body (e.g. bromadiolone, bro-
difacoum and flocoumafen). There is additional risk of acquiring and retaining residues
from secondary poisoning or tertiary poisoning as well as from baits with these
compounds.
Secondary poisoning and non-target risk
The tendency to bioaccumulate is linked with non-target and secondary poisoning risks
and clearly, this risk, as indicated in Table 4 above, will be less for D + C baits versus bro-
difacoum. There is also much less risk of secondary poisoning of non-target species from
carcasses or sub-lethally poisoned animals.
Table 4. Classification of vertebrate pesticides based on comparative pharmacokinetics and
expectation of persistence of residues in sub-lethally exposed species (adapted from Eason et al.
2010b).
Group Compound Half-life values Likely persistence of residues in edible tissues
1 Cyanide + 12–24 h
Zinc phosphide + 12–24 h
Para-aminopropiophenone + 4 days
1080 <11 h 7 days
2 Pindone 2.1 days 4 weeks
Diphacinone 3 days in rats 6 weeks
3 Cholecalciferol 10–68 days 3 months but note: it is always present
at normal physiological concentrations
Coumatetralyl 50–70 days 4 months
4 Brodifacoum 130 days 24 months or longer
Bromodiolone 170 days 24 months or longer
Flocoumafen 220 days 24 months or longer
Note: + no published value but likely to be <12 h.
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Secondary poisoning risk from diphacinone and cholecalciferol as sole agents in car-
casses has previously been shown to be low (Eason et al. 2013) when compared to com-
pounds like 1080 and brodifacoum. This earlier work with diphacinone and
cholecalciferol as sole agents has also shown secondary poisoning risks to birds, dogs
and cats to be low (Eason et al. 2000, 2013; US EPA 2008; Lima and Salmon 2010).
However, there are no published reports on the D + C combination and secondary
poisoning and non-target risk. Nevertheless, as mentioned previously the combination
of coumatetralyl (0.03%w/w) and cholecalciferol (0.015%w/w) was extensively studied
prior to the realisation that diphacinone and cholecalciferol would be a safer alternative
(Crowell et al. 2013). For example, secondary poisoning studies were conducted with
poisoned carcasses fed to chickens and dogs and non-target species were exposed to
bait (Henderson 2006, 2009; Henderson et al. 2006, 2008). Secondary poisoning risks
were shown to be low as were primary poisoning risks to non-targets for those species
tested, when compared to brodifacoum (Eason et al. 2002, 2013). Similar low secondary
poisoning and non-target risk could be expected for the combination of diphacinone
and cholecalciferol.
Discussion
Brodifacoum is used extensively for sustained ground control of possums and rats on the
New Zealand mainland and aerial pest eradication on offshore islands. It is a very effective
and important tool for rodent eradication (Broome et al. 2010); however, continuous use
of brodifacoum can result in bioaccumulation of residues in non-target wildlife and sec-
ondary poisoning risk. Brodifacoum is highly persistent when compared with diphacinone
(Eason et al. 1996, 2002, 2010a, 2010b; Fisher et al. 2003; Crowell et al. 2013). The new
cereal bait we have described in this publication has the potential to play a key role in con-
trolling possums and rodents alongside other tools for conservation and TB vector man-
agement and reduce over-use of brodifacoum, which can result in bioaccumulation of
residues in non-target wildlife if it is used continually.
First-generation anticoagulants like diphacinone are effective rodenticides and have
also been used to control ferrets in New Zealand (Spurr et al. 2005), but we know these
anticoagulants are not effective against possums unless large amounts are eaten (Eason
and Jolly 1993; Eason et al. 1994, 2010a, 2010b). Cholecalciferol, a naturally occurring
substance (Fairweather et al. 2013), is effective, with lower risk of secondary poisoning
or toxicity to birds (Eason et al. 2000, 2013), for controlling rats and possums (Marshall
1984; Eason 1991; Eason et al. 2000, 2010a, 2010b), but has to be used at comparatively
high concentrations when used as a sole agent to kill possums and rats (Eason et al.
2010a, 2010b).
We have used the knowledge that a low dose of cholecalciferol will increase the potency
of anticoagulant rodenticides (Pospischil and Schnorbach 1994; Kerins et al. 2002; Kocher
and Navjot 2013), and built on past research which explored a combination of coumate-
tralyl and cholecalciferol (Henderson et al. 2008), similar to that previously developed in
Europe (Pospischil and Schnorbach 1994). As described in this paper we have produced a
new bait with favourable risk versus benefit profile and exploited the low relative persist-
ence of diphacinone versus coumatetralyl, noting the estimated half-life of coumatetralyl is
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56 days in rats versus less than 1 week for diphacinone in rats (Singleton et al. 2003;
Kocher and Navjot 2013).
The combination of diphacinone and cholecalciferol in cereal bait has been shown to be
both palatable and effective at killing possums, ship rats and potentially mice. The additive
effect of a small amount of cholecalciferol with diphacinone was clear when compared to
previous results from trials that tested the efficacy of baits containing diphacinone alone,
for rodent control (Hix et al. 2010). The average time to death for captive ship rats was
approximately two days quicker than that reported for captive rats presented with baits
containing just diphacinone at the same concentration (Hix et al. 2010) and two days
quicker than captive ship rats dosed with baits containing brodifacoum (0.002%) for rat
control (Littin et al. 2000). Whilst this result is positive the authors note that the
captive animals used in these studies were on reduced rations and full access to food
could influence the time to death in the field.
As noted in our review of the welfare literature, brodifacoum is not considered to
be humane (Gregory et al. 1998; Littin et al. 2000, 2002, 2009; Eason et al. 2002;
O’Connor et al. 2007). We believe the new diphacinone and cholecalciferol bait offers a
comparative improvement. The average time to death for captive possums was 5.77 days
which is significantly faster than the average of 20.1 days reported for captive possums
dosed with brodifacoum baits (Littin et al. 2000), which is important as large amounts of
brodifacoum bait can be eaten before death. The intention is that the new bait will be
used for controlling possums and rats and not require a professional licence for use so
that it is equivalent to second-generation anticoagulants from efficacy and regulatory
standpoint. The field trials completed to date have confirmed laboratory results and they
have been used to support product registration. The field results also compare favourably
to reported kills of rodents using brodifacoum (Innes et al. 1995) and also possums
(Henderson et al. 1994); however, there is a lack of published information on the field
efficacy of brodifacoum used alone for possums. Larger scale field experience will lead to
further optimisation of baiting practices and best practice use. In the future, we believe
further research is worth pursuing in three different areas. Firstly, further field trials are
warranted to optimise the field use of the new baits. Secondly, unpublished laboratory
trials show that a combination bait containing cholecalciferol at half (0.03%) or a
quarter (0.015%) the concentration used in current bait is still effective for killing rats
(pers. comm. Lee Shapiro 2018). Hence, where only rodents are being targeted, versus
occasions where both possums and rodents are the target, a bait with less cholecalciferol
would be suitable, less hazardous and less costly. Thirdly, repeat, resetting toxin delivery
systems that exclude non-targets called ‘Spitfires’ have been shown to have potential, used
in a DOC200 trap box (Blackie et al. 2016; Murphy et al. 2018) and preliminary trials
with a paste containing diphacinone at 0.005% and cholecalciferol at 0.06% killed nine
out of ten possums (pers. comm. Lee Shapiro 2018). Targeted delivery using Spitfire
devices for rats and possums remains an aspiration for the future (Eason et al. 2017) as
they would limit risk to non-target species and complement the development of solid
extruded cereal baits containing diphacinone and cholecalciferol described in this paper.
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